DGNM.F Stock Overview
Diagnamed Holdings Corp., a digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Diagnamed Holdings Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.034 |
| 52 Week High | CA$0.069 |
| 52 Week Low | CA$0.023 |
| Beta | 0 |
| 1 Month Change | -15.76% |
| 3 Month Change | 26.20% |
| 1 Year Change | -7.07% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 32.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| DGNM.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | 2.8% | 3.3% |
| 1Y | -7.1% | -3.7% | 25.8% |
Return vs Industry: DGNM.F underperformed the US Healthcare Services industry which returned -5.9% over the past year.
Return vs Market: DGNM.F underperformed the US Market which returned 25.1% over the past year.
Price Volatility
| DGNM.F volatility | |
|---|---|
| DGNM.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 9.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DGNM.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine DGNM.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Fabio Chianelli | www.diagnamed.com |
Diagnamed Holdings Corp., a digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders. It focuses on CERVAI, a brain health AI platform; and Health GenAI, a suite of generative AI solutions for the healthcare market that includes OpenAI's ChatGPT. The company also develops Dr. GENAI, a personal AI medical chatbot designed to give people to obtain fast and personalized medical information based on a person’s unique medical condition.
Diagnamed Holdings Corp. Fundamentals Summary
| DGNM.F fundamental statistics | |
|---|---|
| Market cap | US$2.34m |
| Earnings (TTM) | -US$648.29k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-3.2x
P/E RatioIs DGNM.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DGNM.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$888.99k |
| Earnings | -CA$888.98k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did DGNM.F perform over the long term?
See historical performance and comparison